CHER trial landmark study

29 Jun 2014

A landmark South African study conducted in Soweto and Cape Town, has shown that administering antiretroviral therapy (ART) to infants immediately after diagnosis, rather than waiting for their CD4 counts to drop or other symptoms to prompt treatment, reduced their chance of dying by 76%.

It also reduced the chance of their disease progressing measurably by 75%. The findings were so conclusive that after review of the preliminary data, all the babies in the trial were re-assessed for ART.

Further information: